Financial writer discusses Humana's premarket drop due to Cigna's share repurchase plans, impacting ...

Humana (HUM) stock in focus as company raises MA membership guidance with its Q3 2024 resuls despite setbacks this year. Read ...

Humana’s earnings beat Wall Street expectations, but the insurer said 2025 results might come in lower than analysts project, ...

The company said third-quarter earnings per share were $4.16 on revenue of $29.4 billion. Analysts anticipated earnings per ...

Humana (NYSE:HUM) quickly fell 5% in premarket trading at least party amid some Cigna (CI) comments about share repurchases.

TD Cowen raised the firm’s price target on Humana (HUM) to $268 from $261 and keeps a Hold rating on the shares. The firm said the ...

In a report released yesterday, Steve Baxter from Wells Fargo maintained a Buy rating on Humana (HUM – Research Report), with a price ...

The insurer said it doesn’t expect earnings growth next year due to significant investments it plans to make to boost MA ...

Humana reported a $480 million profit and higher-than-expected growth of its Medicare Advantage business that has been hit with higher costs.

Humana's Q3 EPS of $4.16 beat estimates but fell year-over-year. Revenue rose to $29.3 billion, driven by Medicare Advantage ...

The executive comes with more than four decades of experience at the country's largest financial institutions.

Humana has faced a series of shocks this year, including surprise jumps in expenses and a deterioration in crucial Medicare ...